Table 2: Reasons for study exclusion.
Exclusion group |
Reason for exclusion |
Records |
Level 1: Title and abstract screening (n = 147) |
||
Irrelevant exposure |
Irrelevant (no quinolone tested) |
23 |
Irrelevant publication type |
Case report/case series |
101 |
Letter/commentary |
19 |
|
Report |
3 |
|
Conference abstract |
1 |
|
Level 2: Full-text examination (n = 2,527) |
||
Irrelevant exposure |
Quinolone combined with other drugs |
294 |
Cross-over trial |
196 |
|
Trial with multiple arms |
150 |
|
Quinolone in a topical formulation |
129 |
|
Trial with a single arm |
100 |
|
Quinolones on multiple arms |
73 |
|
Irrelevant methods |
Observational study |
147 |
Review article |
102 |
|
Not a clinical trial |
17 |
|
Irrelevant outcome |
No results available |
181 |
Current or prior eye disease |
7 |
|
Unavailable full-text |
Reference could not be retrieved |
13 |
Non-original |
Additional reports on original studies |
973 |
Eligible trials with no RD |
Eligible trial with no reporting on RD |
145 |